Quest PharmaTech Inc

Entity type image
Type: Company
Name: Quest PharmaTech Inc
First reported Apr 13 2013 - Updated Apr 13 2013 - 1 reports

Quest inks license pact with UCLA to develop & market anti-PSA IgE technology for treatment of cancer

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, has recently signed an exclusive license agreement with University of California at Los Angeles (UCLA) to develop and market anti-PSA ... [Published PharmaBiz - Apr 13 2013]
First reported Apr 10 2013 - Updated Apr 10 2013 - 1 reports
UCLA
UCLA

Quest signs licensing deal with UCLA for anti - PSA IgE technology

Quest PharmaTech has signed an exclusive licensing deal with University of California at Los Angeles (UCLA) for anti - PSA IgE technology. ... [Published PBR - News - Apr 10 2013]
First reported Apr 09 2013 - Updated Apr 09 2013 - 2 reports

Quest PharmaTech to develop market antiPSA IgE technology for cancer treatment

Home » Syndicated Content » Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatmentQuest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently ... [Published BioPortfolio - Apr 09 2013]

Quotes

...Quest holds numerous patents for the use of tumor associated monoclonal antibodies as immune modulators. "Both IgG and IgE technologies are complementary and provide a novel approach for enhancing the effectiveness of chemotherapy while activating specific immunity to fight the cancer" commented Dr Madi R Madiyalakan, CEO of the Company
Quest inks license pact with UCLA to develop & market anti-PSA IgE technology for treatment of ca ... [Published PharmaBiz - Apr 13 2013]
More From BioPortfolio on "Quest signs licensing deal with UCLA for anti - PSA IgE technology"
Quest signs licensing deal with UCLA for anti PSA IgE technology [Published BioPortfolio - Apr 10 2013]
More From BioPortfolio on "Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment"
Quest PharmaTech to develop market antiPSA IgE technology for cancer treatment [Published BioPortfolio - Apr 09 2013]

More Content

All (9) | News (5) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Ovarian Cancer - Pipeline Review, H1 2013 - New... [Published Live-PR.com - Apr 25 2013]
Monday Deal Review: April 22, 2013 [Published The Cross-Border Biotech Blog - Apr 22 2013]
Quest inks license pact with UCLA to develop & ... [Published PharmaBiz - Apr 13 2013]
Quest signs licensing deal with UCLA for anti ... [Published BioPortfolio - Apr 10 2013]
Quest signs licensing deal with UCLA for anti -... [Published PBR - News - Apr 10 2013]
Quest PharmaTech to develop market antiPSA IgE ... [Published BioPortfolio - Apr 09 2013]
Quest PharmaTech licenses anti-PSA IgE tech fro... [Published Stockwatch - Apr 09 2013]
Quest PharmaTech Signs Exclusive License Agreem... [Published PR Newswire: Health - Apr 09 2013]
Quest PharmaTech Enrolls 40th Patient in its Ph... [Published PR Newswire: Health - Jan 22 2013]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Monday Deal Review: April 22, 2013 [Published The Cross-Border Biotech Blog - Apr 22 2013]
Welcome to your Monday Biotech Deal Review for April 22, 2013! Aeterna Zentaris has had a busy two weeks on the commercial front, signing agreements with Merck and Ergomed.  However, there was a lot more action as well.  Hit the break to catch up on ...
Quest signs licensing deal with UCLA for anti -... [Published PBR - News - Apr 10 2013]
Quest PharmaTech has signed an exclusive licensing deal with University of California at Los Angeles (UCLA) for anti - PSA IgE technology. ...
1

Press Releases

sort by: Date | Relevance
Quest PharmaTech Signs Exclusive License Agreem... [Published PR Newswire: Health - Apr 09 2013]
Quest PharmaTech Enrolls 40th Patient in its Ph... [Published PR Newswire: Health - Jan 22 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.